Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Clinical Epilepsy

Friday 04/15/11
09:00 AM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Full-Day Course
Elson L. So, MD, FÂ鶹´«Ã½Ó³»­
Participants should be able to apply classifications of seizures and epilepsy to guide diagnostic evaluation and treatment of these conditions; differentiate the advantages and disadvantages between older and newer antiepileptic drugs; manage seizures and epilepsy before, during, and after pregnancy; distinguish between epileptic seizures, pseudoseizures, and other mimicking spells, including parasomnias and other sleep-related disorders; promptly recognize and manage psychiatric comorbidities of epilepsy; advise patients on their treatment options and prognosis when a period of seizure remission has been achieved; decide on the appropriate options for treating antiepileptic drug-resistant epilepsy.
No CME available
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Interactive, Audience Participation
Event Timeline
09:00 AM - 09:45 AM How to Classify Seizures and Epilepsy
Susan T. Herman, MD, FÂ鶹´«Ã½Ó³»­
09:45 AM - 10:30 AM Modern Antiepileptic Drugs: Are They Better?
Suzette M. LaRoche, MD, FÂ鶹´«Ã½Ó³»­
10:30 AM - 10:45 AM Break
10:45 AM - 11:30 AM Epilepsy in Women: Special Considerations
Kimford J. Meador, MD, FÂ鶹´«Ã½Ó³»­
11:30 AM - 12:15 PM Sleep and Epilepsy: Distinguishing Strange Bedfellows
Bradley V. Vaughn, MD, FÂ鶹´«Ã½Ó³»­
12:15 PM - 12:30 PM Questions and Answers
12:30 PM - 01:30 PM Lunch
01:30 PM - 02:15 PM Pseudoseizures and Pseudo-Pseudoseizures: Diagnosis and Management
William O. Tatum IV, DO, FÂ鶹´«Ã½Ó³»­
02:15 PM - 03:00 PM Psychiatric Co-Morbidities of Epilepsy
W. C. LaFrance, Jr., MD, MPH, FÂ鶹´«Ã½Ó³»­
03:00 PM - 03:15 PM Break
03:15 PM - 04:00 PM My Patient Is Seizure Free: Now What Do I Do?
Carl W. Bazil, MD, PhD, FÂ鶹´«Ã½Ó³»­
04:00 PM - 04:45 PM My Patient Is Medically Intractable: Now What Do I Do?
Elson L. So, MD, FÂ鶹´«Ã½Ó³»­
04:45 PM - 05:00 PM Questions and Answers
Faculty Disclosures
Susan T. Herman, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Herman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioserenity. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for National Association of Epilepsy Centers. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Herman has received research support from Epilepsy Foundation; Epilepsy Learning Healthcare System. The institution of Dr. Herman has received research support from CREMedical. The institution of Dr. Herman has received research support from NIH/NINDS. The institution of Dr. Herman has received research support from Marinus. The institution of Dr. Herman has received research support from Neuroelectrics, Inc. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as a Medical Director, Neurodiagnostics Program with Laboure College. Dr. Herman has a non-compensated relationship as a Professional Advisory Board member with Epilepsy Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Bradley V. Vaughn, MD, FÂ鶹´«Ã½Ó³»­ Dr. Vaughn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Â鶹´«Ã½Ó³»­ Resources. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has a non-compensated relationship as a speaker/course director with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Elson L. So, MD, FÂ鶹´«Ã½Ó³»­ Dr. So has nothing to disclose.
Carl W. Bazil, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bazil has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medical Letter . Dr. Bazil has received publishing royalties from a publication relating to health care.
William O. Tatum IV, DO, FÂ鶹´«Ã½Ó³»­ Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a Â鶹´«Ã½Ó³»­ Section Chair of Clinical Neurophysiology with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
W. C. LaFrance, Jr., MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Suzette M. LaRoche, MD, FÂ鶹´«Ã½Ó³»­ Dr. LaRoche has received intellectual property interests from a discovery or technology relating to health care. Dr. LaRoche has received publishing royalties from a publication relating to health care. Dr. LaRoche has a non-compensated relationship as a President with American Clinical Neurophysiology Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Kimford J. Meador, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.